Tailong Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Tailong

Tailong

Henan Tailong Pharmaceutical Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Henan Tailong Pharmaceutical Co., Ltd. was founded in 1993. Its main business is drug manufacturing and drug research and development services, including four sectors: pharmaceutical preparations, Chinese herbal medicines, drug research and development services and drug and medicinal materials circulation. The main products include Shuanghuanglian Oral Liquid Series, Shuangjin Combination Agent, Salvia miltiorrhiza oral liquid, Children's Heat-Clearing and Cough-Relieving Oral Liquid, Children's Compound Chicken Neijin Chewable Tablets, Haxylazine A Tablets, etc. Among them, Shuanghuanglian Oral Liquid (Concentrated Type), Shuanghuanglian Oral Liquid (Children Type), Shuangjin Combination Agent and Pediatric Compound Chicken Neijin Chewable Tablets are the company's exclusive products.

In 1999, Tailong Pharmaceutical's stock was grandly listed on the Shanghai Stock Exchange and became a listed company in the pharmaceutical industry in Henan Province. After more than 20 years of development, Tailong Pharmaceutical has indirectly participated in and controlled more than a dozen subsidiaries (branches), covering related fields such as pharmaceutical manufacturing, drug research and development, capital operation, etc., and its main economic indicators are in the pharmaceutical industry in Henan Province. Ranked at the forefront of the middle. The company organizes production carefully based on market demand. During the production process, strictly follow the GMP requirements, implement quality management throughout the production process, and conduct inspections in accordance with the drug pharmacopoeia standards, drug registration standards and enterprise internal control standards to ensure safe production and stable drug quality.

The company mainly adopts the "distribution and distribution" sales model, establishes a nationwide marketing network, and uses the channel resources and distribution advantages of dealers to achieve coverage of grade hospitals, primary medical institutions and retail terminals. At the same time, the company's own sales team has professionally Strengthen the service and management of terminals through academic promotion, brand promotion, market promotion and other means; the company also expands the product terminal market by deepening strategic cooperation with major chain pharmacies, and continuously expands its brand influence in the industry and consumers.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号